Uploads
Contact
/
Login
Upload
Search Results for 'Risk Inhibitors'
Development Committee CHAIR
kittie-lecroy
Medications Used in the Treatment of Diabetes Mellitus
sherrill-nordquist
Enablers and Inhibitors for Expediting Systems and Software
olivia-moreira
Antifungal agents
celsa-spraggs
PARP Inhibitors This program will include a discussion of off-label treatment and investigational
conchita-marotz
Chapter 44 Drugs Acting on the Renin-Angiotensin-Aldosterone System
alida-meadow
Novel Oral Anticoagulants
natalia-silvester
The Use of PARP Inhibitors in Breast Cancer: Challenges
calandra-battersby
Chapter 32 Antidepressants
liane-varnes
Endocrine Treatment of Metastatic Breast Cancer: New Advances; Patient Education Implications
calandra-battersby
Internal use only Timing and Approach of Combination Therapy
kittie-lecroy
Nuclear Transport Inhibitors Alter Capsid Subcellular
calandra-battersby
Stillbirth in HIV-infected women delivering in UK/Ireland between 2007 and 2015
yoshiko-marsland
RTK inhibitors much as bacteria do in response to ant
liane-varnes
FDA warns that SGLT2 inhibitors for diabetes may result in a serious c
debby-jeon
Proteasome Inhibitors in Atrophying Skeletal Muscle J
briana-ranney
The VIGOR and CLASS Trials: Cox-2 Inhibitors in the Dock The Celebrex
pasty-toler
DOCK is academic software developed over many years by investigators i
phoebe-click
CamridgeSomrvilleWatertownBrookline
marina-yarberry
Multi-Chems Low Dosage Hydrate Inhibitors (LDHI) eectively ...
pasty-toler
Risk Assessment and Risk Reduction Strategies for Known Off
jane-oiler
2017 RISK UPDATE Keep calm and take a risk…
tawny-fly
Engineer’s Perceptions of Risk
mitsue-stanley
Value at Risk: Market Risk Models
kittie-lecroy
1
2
3
4
5
6
7
8